Cellular aging in neurons made from people with Alzheimer's

Assessing cellular aging in old and rejuvenated neurons from Alzheimer patients

NIH-funded research Salk Institute for Biological Studies · NIH-11297619

Seeing whether making neurons from patients' skin cells reveals aging-related changes and ways to restore healthier neurons for people with Alzheimer's.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSalk Institute for Biological Studies NIH-funded
Lab location1 site (La Jolla, UNITED STATES)
Project IDNIH-11297619 on NIH RePORTER

What this research studies

Researchers take skin cells from people with Alzheimer's and convert them into neurons that keep signs of biological aging so they can be studied in the lab. They compare 'old' patient-derived neurons with neurons that have been experimentally rejuvenated to find what makes Alzheimer's neurons vulnerable. The team focuses on metabolism and a molecule called PKM2 that seems to drive harmful changes in neuron identity and function. Findings may point to targets for drugs or interventions that protect memory cells.

Who could benefit from this research

Good fit: Adults diagnosed with Alzheimer disease who can provide a skin biopsy or other patient-derived cells would be ideal candidates to contribute samples for this work.

Not a fit: People who cannot provide a tissue sample, who have other types of dementia, or who expect an immediate treatment benefit are unlikely to directly benefit from this laboratory-focused research.

Why it matters

Potential benefit: If successful, this work could point to new targets or strategies to restore healthy metabolism and identity in Alzheimer’s neurons, helping guide future treatments.

How similar studies have performed: This builds on recent lab work showing that induced neurons from AD patients keep aging signatures and implicate PKM2, but translating those findings to treatments is still early and unproven in patients.

Where this research is happening

La Jolla, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.